Literature DB >> 25250553

Neuroimaging of HIV-associated neurocognitive disorders (HAND).

Beau M Ances1, Dima A Hammoud.   

Abstract

PURPOSE OF REVIEW: HIV enters the brain after initial infection, and with time can lead to HIV-associated neurocognitive disorders (HAND). Although the introduction of combination antiretroviral therapy has reduced the more severe forms of HAND, milder forms are still highly prevalent. The 'gold standard' for HAND diagnosis remains detailed neuropsychological performance testing but additional biomarkers (including neuroimaging) may assist in early detection of HAND. RECENT
FINDINGS: We review the application of recently developed noninvasive MRI and PET techniques in HIV+ individuals. In particular, magnetic resonance spectroscopy may be more sensitive than conventional MRI alone in detecting HIV associated changes. Diffusion tensor imaging has become increasingly popular for assessing changes in white matter structural integrity due to HIV. Both functional MRI and PET have been limitedly performed but could provide keys for characterizing neuropathophysiologic changes due to HIV.
SUMMARY: It is hoped that continued progress will allow novel neuroimaging methods to be included in future HAND management guidelines.

Entities:  

Mesh:

Year:  2014        PMID: 25250553      PMCID: PMC4217490          DOI: 10.1097/COH.0000000000000112

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  105 in total

1.  Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.

Authors:  Mona A Mohamed; Peter B Barker; Richard L Skolasky; Ola A Selnes; Richard T Moxley; Martin G Pomper; Ned C Sacktor
Journal:  Magn Reson Imaging       Date:  2010-08-04       Impact factor: 2.546

2.  A comparative evaluation of quantitative neuroimaging measurements of brain status in HIV infection.

Authors:  Hongyan Du; Ying Wu; Renee Ochs; Robert R Edelman; Leon G Epstein; Justin McArthur; Ann B Ragin
Journal:  Psychiatry Res       Date:  2012-08-12       Impact factor: 3.222

3.  Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

Authors:  David F Tate; Mehul Sampat; Jaroslaw Harezlak; Mark Fiecas; Joseph Hogan; Jeffrey Dewey; Daniel McCaffrey; Daniel Branson; Troy Russell; Jared Conley; Michael Taylor; Giovanni Schifitto; Giavoni Schifitto; J Zhong; Eric S Daar; Jeffrey Alger; Mark Brown; Elyse Singer; T Campbell; D McMahon; Y Tso; Janetta Matesan; Scott Letendre; S Paulose; Michelle Gaugh; C Tripoli; Constantine Yiannoutsos; Erin D Bigler; Ronald A Cohen; Charles R G Guttmann; Bradford Navia
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

4.  Neuroimaging markers of human immunodeficiency virus infection in South Africa.

Authors:  Jodi M Heaps; John Joska; Jackie Hoare; Mario Ortega; Aleena Agrawal; Soraya Seedat; Beau M Ances; Dan J Stein; Robert Paul
Journal:  J Neurovirol       Date:  2012-04-12       Impact factor: 2.643

Review 5.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

6.  Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men.

Authors:  Karen J Towgood; Mervi Pitkanen; Ranjababu Kulasegaram; Alex Fradera; Suneeta Soni; Naomi Sibtain; Laurence J Reed; Caroline Bradbeer; Gareth J Barker; Joel T Dunn; Fernando Zelaya; Michael D Kopelman
Journal:  Hum Brain Mapp       Date:  2012-04-12       Impact factor: 5.038

7.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia.

Authors:  E H Aylward; P D Brettschneider; J C McArthur; G J Harris; T E Schlaepfer; J D Henderer; P E Barta; A Y Tien; G D Pearlson
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

8.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

9.  Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.

Authors:  J Mimi Boer Castelo; Maureen G Courtney; Rebecca J Melrose; Chantal E Stern
Journal:  Arch Neurol       Date:  2007-09

10.  Early microstructural white matter changes in patients with HIV: a diffusion tensor imaging study.

Authors:  Bianca Stubbe-Drger; Michael Deppe; Siawoosh Mohammadi; Simon S Keller; Harald Kugel; Nora Gregor; Stefan Evers; Peter Young; E-Bernd Ringelstein; Gabriele Arendt; Stefan Knecht; Ingo W Husstedt
Journal:  BMC Neurol       Date:  2012-05-01       Impact factor: 2.474

View more
  40 in total

Review 1.  Novel Neuroimaging Methods to Understand How HIV Affects the Brain.

Authors:  Paul M Thompson; Neda Jahanshad
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

2.  Identifying the white matter impairments among ART-naïve HIV patients: a multivariate pattern analysis of DTI data.

Authors:  Zhenchao Tang; Zhenyu Liu; Ruili Li; Xin Yang; Xingwei Cui; Shuo Wang; Dongdong Yu; Hongjun Li; Enqing Dong; Jie Tian
Journal:  Eur Radiol       Date:  2017-04-10       Impact factor: 5.315

3.  Proton Chemical Shift Imaging Study of the Combined Antiretroviral Therapy Impact on Neurometabolic Parameters in Chronic HIV Infection.

Authors:  J Boban; D Kozic; V Turkulov; D Lendak; M Bjelan; M Semnic; S Brkic
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

Review 4.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification.

Authors:  Yong Zhang; Dongjin Kwon; Pardis Esmaeili-Firidouni; Adolf Pfefferbaum; Edith V Sullivan; Harold Javitz; Victor Valcour; Kilian M Pohl
Journal:  Hum Brain Mapp       Date:  2016-08-04       Impact factor: 5.038

Review 6.  Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Authors:  Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-22       Impact factor: 4.147

7.  Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Authors:  Laura M Campbell; Christine Fennema-Notestine; Rowan Saloner; Mariam Hussain; Anna Chen; Donald Franklin; Anya Umlauf; Ronald J Ellis; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; J Allen McCutchan; Scott Letendre; Igor Grant; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2019-10-02       Impact factor: 2.892

Review 8.  Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms.

Authors:  Mollie A Monnig
Journal:  Am J Drug Alcohol Abuse       Date:  2016-08-17       Impact factor: 3.829

9.  HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.

Authors:  Jasmina Boban; Dusko Kozic; Vesna Turkulov; Jelena Ostojic; Robert Semnic; Dajana Lendak; Snezana Brkic
Journal:  Eur Radiol       Date:  2017-03-14       Impact factor: 5.315

Review 10.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.